Can You Get Re-Irradiation with Proton Therapy After Cancer Recurs? (2026 Guide)

Whether proton therapy can be repeated at a site that already received radiation depends on the previous irradiated area, the total prior dose, and how much time has passed — and proton therapy specifically treats this kind of re-irradiation scenario as one of its potential indications.

Key Takeaways

• Proton therapy is a treatment option that considers re-irradiation even at sites that previously received radiation, in cases of recurrence (per proton therapy guidance materials).
• Whether re-irradiation is feasible is determined during the remote review (pre-arrival review) stage, based on records of the prior irradiated area, total dose, number of fractions, and treatment dates.
• Because protons stop at the tumor with the Bragg peak effect — meaning almost no radiation passes beyond the target — re-irradiation can be considered while reducing the risk of further damage to surrounding tissue that already received radiation once before.
• Conventional radiotherapy can sometimes also be repeated at the same site, but feasibility depends on the prior dose and the time elapsed.
• Heavy-ion therapy may likewise be considered for recurrence at a previously irradiated site, but it equally requires complete records of the prior irradiation.

Can I Receive Proton Therapy Again If My Cancer Recurs?

• In some cases, yes. Proton therapy guidance materials list 'whether treatment can be repeated at a site that already received radiotherapy' as one of the most common patient questions, and explicitly describe 're-irradiation needed because recurrence occurred at a site that previously received radiotherapy' as the fourth category of indications for proton therapy.
• Two factors determine feasibility: first, the total dose and number of fractions the area previously received; second, how much time has passed since that treatment. Because normal tissue recovers to some degree over time, the possibility of re-irradiation at the same site varies depending on the prior dose and the interval that has elapsed.
• The Bragg peak property of protons — stopping at the tumor with almost no radiation continuing beyond it — can work in favor of limiting additional damage to normal tissue surrounding the tumor that has already received one round of radiation. However, this is a general principle; whether re-irradiation is actually feasible for an individual patient can only be confirmed by reviewing imaging together with the past treatment records.

How Is Re-Irradiation Feasibility Confirmed? (Procedure)

• Step 1 — Gather records of the prior radiotherapy. The key items are the irradiated area, total dose, number of fractions, and treatment dates.
• Step 2 — Prepare recent CT/MRI scans in original DICOM format, along with the corresponding reading/interpretation report. These serve as the basis for confirming the location and extent of the recurrence.
• Step 3 — Submit biopsy and pathology reports together with your surgical and chemotherapy history.
• Step 4 — During the remote review (pre-arrival review) stage, these records are used to determine whether re-irradiation is feasible or whether a new treatment plan needs to be developed. The remote review fee is KRW 1,000,000, and this amount is deducted from the treatment cost if you subsequently contract for treatment.
• Step 5 — If treatment is deemed feasible, simulation imaging, fabrication of an immobilization device, and treatment planning take 1–2 weeks, followed by outpatient visits five times a week for a total of 10–35 sessions of irradiation.

FAQ — Is Proton Therapy or Conventional Radiotherapy Better Suited for Re-Irradiation?

There is no fixed answer. Protons have the characteristic of delivering almost no radiation to tissue beyond the tumor, which is why they are sometimes considered for re-irradiation situations; conventional radiotherapy can also sometimes be repeated depending on the prior dose and elapsed time. Which option is appropriate is determined by reviewing the prior irradiation records together with the location of the recurrence.

FAQ — Can a Decision Be Made Based Solely on Radiotherapy Records from Another Country?

Yes. Proton therapy guidance materials explain that if you bring the irradiated-area and dose records from treatment received abroad, the review stage can determine whether treatment can proceed directly or whether a new plan needs to be developed. The more detailed the records, the more accurately feasibility for re-irradiation can be confirmed.

Sources and Notes

• This article was written based on guidance materials on proton therapy, radiotherapy, and heavy-ion therapy, drawing on information from the National Cancer Center Korea, NCCN patient guidelines, and Medical Korea (medicalkorea.or.kr).
• This content is intended for general medical information purposes only. Diagnosis, treatment methods, and outcomes may vary depending on an individual's condition. Accurate diagnosis and treatment decisions should always be made in consultation with medical professionals.